PL93689B1 - - Google Patents

Download PDF

Info

Publication number
PL93689B1
PL93689B1 PL1975177303A PL17730375A PL93689B1 PL 93689 B1 PL93689 B1 PL 93689B1 PL 1975177303 A PL1975177303 A PL 1975177303A PL 17730375 A PL17730375 A PL 17730375A PL 93689 B1 PL93689 B1 PL 93689B1
Authority
PL
Poland
Prior art keywords
virus
influenza
components
vaccine
immunizing
Prior art date
Application number
PL1975177303A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL93689B1 publication Critical patent/PL93689B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
PL1975177303A 1974-01-14 1975-01-13 PL93689B1 (Direct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (Direct) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
PL93689B1 true PL93689B1 (Direct) 1977-06-30

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1975177303A PL93689B1 (Direct) 1974-01-14 1975-01-13

Country Status (27)

Country Link
JP (2) JPS58407B2 (Direct)
AT (1) AT345449B (Direct)
AU (1) AU500250B2 (Direct)
BE (1) BE824372A (Direct)
CA (1) CA1049406A (Direct)
CH (1) CH589453A5 (Direct)
CS (1) CS191254B2 (Direct)
DD (1) DD116239A5 (Direct)
DE (1) DE2500785B2 (Direct)
DK (1) DK140003B (Direct)
ES (1) ES433759A1 (Direct)
FI (1) FI54053C (Direct)
FR (1) FR2257305B1 (Direct)
GB (1) GB1498261A (Direct)
HK (1) HK56380A (Direct)
HU (1) HU173920B (Direct)
IE (1) IE40794B1 (Direct)
IL (1) IL46426A (Direct)
MY (1) MY8100204A (Direct)
NL (1) NL166622C (Direct)
NO (1) NO143128C (Direct)
PH (1) PH14458A (Direct)
PL (1) PL93689B1 (Direct)
SE (1) SE427238B (Direct)
SU (1) SU616997A3 (Direct)
YU (1) YU41289B (Direct)
ZA (1) ZA75259B (Direct)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
DE602006019629D1 (de) * 2005-11-01 2011-02-24 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
JP5535910B2 (ja) 2007-08-28 2014-07-02 バクスター・インターナショナル・インコーポレイテッド ウイルスワクチンを生産する方法
KR20160068972A (ko) 2013-11-15 2016-06-15 노파르티스 아게 잔여 세포 배양 불순물의 제거

Also Published As

Publication number Publication date
PH14458A (en) 1981-07-29
DE2500785C3 (Direct) 1980-09-11
DE2500785B2 (de) 1980-01-03
FR2257305A1 (Direct) 1975-08-08
NL166622C (nl) 1981-09-15
CA1049406A (en) 1979-02-27
CH589453A5 (Direct) 1977-07-15
HU173920B (hu) 1979-09-28
JPS56127319A (en) 1981-10-06
NO750031L (Direct) 1975-08-11
NO143128B (no) 1980-09-15
CS191254B2 (en) 1979-06-29
AU500250B2 (en) 1979-05-17
DE2500785A1 (de) 1975-07-31
ATA21475A (de) 1978-01-15
JPS58407B2 (ja) 1983-01-06
JPS50100224A (Direct) 1975-08-08
DK1475A (Direct) 1975-09-01
AT345449B (de) 1978-09-11
IE40794B1 (en) 1979-08-15
NL166622B (nl) 1981-04-15
FI54053B (fi) 1978-06-30
BE824372A (fr) 1975-07-14
GB1498261A (en) 1978-01-18
DD116239A5 (Direct) 1975-11-12
SE427238B (sv) 1983-03-21
FI54053C (fi) 1978-10-10
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
DK140003C (Direct) 1979-10-29
HK56380A (en) 1980-10-16
MY8100204A (en) 1981-12-31
IL46426A0 (en) 1975-04-25
SE7500130L (Direct) 1975-07-15
FI750014A7 (Direct) 1975-07-15
SU616997A3 (ru) 1978-07-25
ES433759A1 (es) 1977-02-16
YU41289B (en) 1987-02-28
YU5875A (en) 1984-04-30
JPS6035326B2 (ja) 1985-08-14
DK140003B (da) 1979-06-05
IL46426A (en) 1978-01-31
FR2257305B1 (Direct) 1982-03-19
AU7730575A (en) 1976-07-15
IE40794L (en) 1975-07-14
NL7500301A (nl) 1975-07-16

Similar Documents

Publication Publication Date Title
Morein et al. Effective subunit vaccines against an enveloped animal virus
Johansson et al. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection
JP5258127B2 (ja) インフルエンザワクチン
JP2812352B2 (ja) 核酸製剤
AU701024B2 (en) Method for preparing an influenza virus, antigens obtained and applications thereof
KR20060052804A (ko) 기능성 인플루엔자 바이러스 유사입자
CN102781469A (zh) 用于生产流感疫苗的方法
RS54306B1 (sr) Vakcina
BR112013000394B1 (pt) Composição imunogênica, uso da mesma e método para preparar a referida composição
US4064232A (en) Process for isolating the immunogenic components of influenza viruses
JP2002532435A (ja) Ｒｓｖサブユニット成分およびインフルエンザウイルス調製物を含む多価免疫原性組成物
PL93689B1 (Direct)
WO2016100922A1 (en) Synergistic co-administration of computationally optimized broadly reactive antigens for h1n1 influenza
US4140762A (en) Influenza sub-unit vaccine
EP2822585B1 (en) Improved vaccination against influenza
Hocart et al. Preparation and characterization of a purified influenza virus neuraminidase vaccine
Virelizier et al. The role of humoral immunity in host defence against influenza A infection in mice
CN110719789A (zh) 疫苗组合物
Voeten et al. Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8+ cytotoxic T lymphocytes
Park et al. Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtration
KR101290475B1 (ko) 인플루엔자 바이러스 및 비형 간염 바이러스로부터의항원을 포함하는 비로좀 입자
RU2193065C2 (ru) Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
Hurwitz et al. Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells.
CA1270438A (en) Influenza vaccine
EP3858380A1 (en) Inactivated whole-virus influenza vaccine and method for preparing same